4
Changes in Ownership
Mineralys Therapeutics, Inc. Filed Acc 0001933414-25-000093
Chief Medical Officer sold 11,365 shares at $12.93 ($146,987)
- Chief Medical Officer acquired 6,349 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Rodman David Malcom Chief Medical Officer | 2025-08-12 | Option exercise 10b5-1 | +6,349 | $1.08 | $6,857 | 104,256 | D |
| Rodman David Malcom Chief Medical Officer | 2025-08-13 | Sale 10b5-1 | −11,365 | $12.93 | $146,987 | 92,891 | D |
| Derivatives | |||||||
| Rodman David Malcom Chief Medical Officer | 2025-08-12 | Option exercise · Stock Option 10b5-1 | −6,349 | 82,531 | D | ||
| Open-market sales · 11,365 sh · avg $12.93 · $146,987 | |||||||
Loading xslF345X05/wk-form4_1755208973.xml…